Os livros estão organizados por ordem alfabética dos títulos.
Os periódicos estão organizados pela ordem alfabética do nome do periódico, e os periódicos com mesmo título, por ordem cronológica de publicação.

Livros

Liv 07 Voltar
Adverse effects of Psychotropic Drugs 1992
John Kane

Liv 01 Voltar
Comprehensive TextBook of Psychaitry 6º Ed. 1995
Kaplan & Sadock

Ref 22
Am J Addict 1997; 6:304-310
Distinguishing Alcoholic Patients With and Without Comorbid Drug Abuse
Anton Porsteinsson, M.D.

Ref 24
Am J Geriatr Psychiatry 1997; 5:324-332
Naltrexone as an Adjunctive Treatment for Older Patients With Alcohol Dependence
David Oslin, M.D

Ref 199
Am J Psychiatry 1993; 150:1037–1042
Dissociative disorders in psychiatric inpatients.
Saxe GN

Ref 59
Am J Psychiatry 1995 152: 1130-1138;
Antidepressants-Induced Mania and Cycled Acceleration: A Controversial revisited
Altshuler, RM Post, GS Leverich, K Mikalauskas, A Rosoff, and L Ackerman

Ref 222
Am J Psychiatry 153: 592-606; 1996
Pharmacologic Management of Psychiatric Illness During Pregnancy: Dilemmas and Guidelines
LL Altshuler, L Cohen, MP Szuba, VK Burt, M Gitlin, and J Mintz

Am J Psychiatry 1997; 154:1107-1113
Feeling Unreal: 30 Cases of DSM-III-R Depersonalization Disorder
Daphne Simeon, M.D.

Ref 139
Am J Psychiatry 1997; 154:1220-1227
Obstetric Complications and Age at Onset in Schizophrenia: An International Collaborative Meta-Analysis of Individual Patient Data
H Verdoux, JR Geddes, N Takei, SM Lawrie, P Bovet, JM Eagles, R Heun, RG McCreadie, TF McNeil, E O'Callaghan, G Stober, MU Willinger, P Wright, and RM Murray


	Referências Bibliográficas

	Os livros estão organizados por ordem alfabética dos títulos. Os periódicos estão organizados pela ordem alfabética do nome do periódico, e os periódicos com mesmo título, por ordem cronológica de publicação. Livros Liv 07 Voltar Adverse effects of Psychotropic Drugs 1992 John Kane Liv 16 Voltar The American Psychaiatric TextBook of Psychopharmacology 1995 Charles B. Nemeroff Liv 14 Voltar APP TextBook of Psychiatry 2º Ed 1994 Robert E. Hales Liv 20 Voltar Child and Adolescent Psychiatry 1991 Melvin Lewis Liv 01 Voltar Comprehensive TextBook of Psychaitry 6º Ed. 1995 Kaplan & Sadock Liv 21 Voltar Comprehensive Review of Geriatric Psychiatry 1991 Joel Sadavoy Liv 12 Voltar Clinical Evaluation of Psychotropic Drugs 1994 Robert Prien Liv 09 Voltar Drug Information HandBook 7º Ed 2000 Liv 02 Voltar DSM IV 1994 Liv 08 Voltar HandBook of Psychiatric Drugs 1992 Bernard Salzman Liv 10 Voltar HandBook of Psychotropic Drugs 1991 Liv 11 Voltar Manual de Farmacologia Psiquiátrica 1993 Kaplan & Sadock Liv 19 Voltar Maniac Depressive Illness Frederick Goodwin Liv 15 Voltar Manual of Clinical Psychopharmacology 2º Ef 1997 Alan F Schatzberg Liv 18 Voltar Medical and nutritional Complications of Alcoholism 1992 Charles Lieber Liv 06 Voltar Primer Drug Action 20º Ed. 1995 Robert M Julien Liv 05 Voltar Psicofármacos 2º Ed 2000 Aristides Volpato Liv 04 Voltar The Practioner's Guide to Psychoactive Drugs 3º Ed 1991 Alan J. Gelenberg Liv 03 Voltar Psychopharmacology The Third Generation of Progress 3º Ed 1987 Herbert Y Meltzer Liv 13 Voltar TextBook of Neuropsychiatry 3º Ed 1997 Yudofsky C. Liv 17 Voltar Treatments of psychiatric Disorders 2º Ed. 1995 Glen O. Gabbard Periódicos Ref 140 Acta Psychiatr Scand 1988; 97: 76-85 Hostilidade e Criticismo dos Parentes de Esquizofrênicos e Outras Psicoses: Predidores Clínicos e Demográficos Ref 270 Acta Psychiatr Scand 92: 250-254; 1995 Predictors of Imminent Violence in Psychiatry Inpatients Ref 308 Acta Psychiatr Scand Suppl. 2000;400:23-7. Safety profile of amisulpride in short- and long-term use. Rein W Ref 78 Addiction; 92(10):1289-304, 1997. The life-time rates of three major mood disorders and four major anxiety disorders in alcoholics and controls Ref 23 Addiction; 4: 487-492 1998 Psychiatric Symptons in Male Cannabis Users not Other Illicit Drug Ref 292 Addiction 96: 1035-1047 2001 Patterns of Recreational Use Drug at Dance Events in Eddinburg Ref 326 Addictive Bevaviors 2000; 4: 579-584 Crack-Cocaine Use and Health Status Russerl Falck Ref 18 Am J Addic 1997; 6:30-37 Influência do Vício nos Filhos Ref 7 Am J Addict 1997; 6:99-104 Social Phobia in Cocaine-Dependent Individuals Ref 19 Am J Addict 1997; 6:224-231 Early Prediction of Initiation of Abstinence From Cocaine: Use of a Craving Questionnaire Ref 21 Am J Addict 1997; 6:232-236 Predictors of Successful vs. Unsuccessful Outcome of a 12-Step Inpatient Alcohol Rehabilitation Program. Thomas J. Craig, M.D. Ref 30 Am J Addict 1997; 6:284-292 Course and Severity of Substance Abuse Among Patients With Comorbid Major Depression Joseph Westermeyer, M.D., Ph.D. Stacy Kopka, B.A. Sean Nugent, B.S. Ref 22 Am J Addict 1997; 6:304-310 Distinguishing Alcoholic Patients With and Without Comorbid Drug Abuse Anton Porsteinsson, M.D. Ref 37 Am J Addict 1997; 6:318-329 Associations Between ADHD and Psychoactive Substance Use Disorders Sharon Milberger Ref 136 Am J Addict 1998; 7:1-6 Diagnosis of Personality Disorders in Cocaine-Dependent Individuals Susan C. Sonne Ref 204 Am J Addict 1998; 7:142–155 Efeito da Fenfluramina no Controle da Dependência a Cocaína Ref 196 Am J Cardiol 1989; 63:1399 –1403 Panic disorder in patients with chest pain and angiographically normal coronary arteries. Beitman BD Ref 163 Am J Epidemiol 1992; 136:95–105 Relations over time between psychiatric and somatic disorders: the Stirling County Study. Murphy JM Ref 24 Am J Geriatr Psychiatry 1997; 5:324-332 Naltrexone as an Adjunctive Treatment for Older Patients With Alcohol Dependence David Oslin, M.D Ref 135 Am J Geriatr Psychiatry 1997; 5:344-351 An Open Trial of Valproate for Agitation in Geriatric Neuropsychiatric Disorders Anton P. Porsteinsson, M.D. Ref 137 Am J Geriatr Psychiatry 1998; 6:5-13 Cerebrovascular Risk Factors and Later-Life Major Depression Jeffrey M. Lyness, M.D Ref 148 Am J Geriatr Psychiatry 1998; 6:24-30 Personality Disorder Symptoms and Functioning in Elderly Depressed Patients Robert C. Abrams Ref 284 Am J Geriatr Psychiatry 1998; 6:83-89 Use of SSRIs in "Very Old" Depressed Nursing Home Residents Brian Trappler, M.D Ref 176 Am J Geriatr Psychiatry 1999; 7:18-33, Testosterona e Depressão nos Homens Ref 282 Am J Geriatr Psychiatry 1999; 7:132-138 Uso da Risperidona nos idosos Ref 281 Am J Geriatr Psychiatry 1999; 7:171-174 ECT em Pacientes Idosos com Esquizofrenia Ref 227 Am J Health Syst Pharm; 55(1):44-9, 1998 Mirtazapine, an antidepressant Ref 125 Am J Med; 1997 103(5):339-47, Depressive and anxiety disorders in patients presenting with physical complaints: clinical predictors and outcome Ref 41 Am J Med 1997; 103: 477-482 Investigação Preliminar no Manejo de Alcoolismo com Naltrexona Ref 200 Am J Psychiatry 1990; 147:1547–1552 Dissociative experiences in the general population. Ross CA Ref 199 Am J Psychiatry 1993; 150:1037–1042 Dissociative disorders in psychiatric inpatients. Saxe GN Ref 246 Am J Psychiatry 1995 152:21-6; Antecedents and Consequences of Negative Life Events in Adulthood Ref 186 Am J Psychiatry 1995; 152:833–842 Stressful life events, genetic liability, and onset of an episode of major depression in women. Kendler KS Ref 245 Am J Psychiatry 1995 152: 1810-1811, Nonresponse to Reinstituted Lithium Prophylaxis in Previousty Responsive Bipolar Patients: Prevalence and Predictors Ref 133 Am J Psychiatry 1995 152: 1124-9; Characteristics and Significance of Untreated Major Depressive Disorder M Maj, R Pirozzi, and L Magliano Ref 59 Am J Psychiatry 1995 152: 1130-1138; Antidepressants-Induced Mania and Cycled Acceleration: A Controversial revisited Altshuler, RM Post, GS Leverich, K Mikalauskas, A Rosoff, and L Ackerman Ref 222 Am J Psychiatry 153: 592-606; 1996 Pharmacologic Management of Psychiatric Illness During Pregnancy: Dilemmas and Guidelines LL Altshuler, L Cohen, MP Szuba, VK Burt, M Gitlin, and J Mintz Ref 9 Am J Psychiatry 1997; 154:773-781 Benzodiazepines and Exposure-Based Cognitive Behavior Therapies for Panic Disorder: Conclusions From Combined Treatment Trials David A. Spiegel, M.D. Ref 16 Am J Psychiatry 1997; 154:832-839 Two-Year Follow-Up of Inpatients With Dissociative Identity Disorder Joan W. Ellason, M.A. Ref 138 Am J Psychiatry 1997; 154:864-866 HIV Infection Among Young Adults With Psychotic Disorders E Susser, P Colson, L Jandorf, A Berkman, J Lavelle, S Fennig, C Waniek, and E Bromet Ref 27 Am J Psychiatry 1997; 154:870-872 Sleep Deprivation Combined With Consecutive Sleep Phase Advance as a Fast-Acting Therapy in Depression: An Open Pilot Trial in Medicated and Unmedicated Patients M Berger, J Vollmann, F Hohagen, A Konig, H Lohner, U Voderholzer, and D Riemann Ref 13 Am J Psychiatry 1997; 154:989-995 Somatization in Cross-Cultural Perspective: A World Health Organization Study in Primary Care Oye Gureje, M.B.B.S. O Gureje, GE Simon, TB Ustun, and DP Goldberg Ref 146 Am J Psychiatry 1997; 154:1101-1106 Reported Pathological Childhood Experiences Associated With the Development of Borderline Personality Disorder Mary C. Zanarini Ref 12 Am J Psychiatry 1997; 154:1107-1113 Feeling Unreal: 30 Cases of DSM-III-R Depersonalization Disorder Daphne Simeon, M.D. Ref 215 Am J Psychiatry 1997; 154:1156-1158 Case-Control Study of Neuroleptic Malignant Syndrome Perminder Sachdev, M.B.B.S. Ref 139 Am J Psychiatry 1997; 154:1220-1227 Obstetric Complications and Age at Onset in Schizophrenia: An International Collaborative Meta-Analysis of Individual Patient Data H Verdoux, JR Geddes, N Takei, SM Lawrie, P Bovet, JM Eagles, R Heun, RG McCreadie, TF McNeil, E O'Callaghan, G Stober, MU Willinger, P Wright, and RM Murray Ref 289 Am J Psychiatry 1997; 154:1248 –1254 Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol. Tollefson GD Ref 6 Am J Psychiatry 1997; 154:1261-1264 Placebo-Controlled Trial of Fluoxetine and Phenelzine for Obsessive-Compulsive Disorder MA Jenike, L Baer, WE Minichiello, SL Rauch, and ML Buttolph Ref 280 Am J Psychiatry 1997; 154:1384-1390 Does Growing Old Increase the Risk for Depression? RE Roberts, GA Kaplan, SJ Shema, and WJ Strawbridge Ref 1 Am J Psychiatry 1997; 154:1412-1416 Clinical Factors Contributing to the Differential Diagnosis of Primary Insomnia and Insomnia Related to Mental Disorders PD Nowell, DJ Buysse, CF Reynolds, 3rd, PJ Hauri, T Roth, EJ Stepanski, MJ Thorpy, E Bixler, A Kales, RL Manfredi, AN Vgontzas, DM Stapf, PR Houck, and DJ Kupfer Ref 142 Am J Psychiatry 1997; 154:1544-1550 Premorbid Social Functioning in Schizophrenia and Bipolar Disorder: Similarities and Differences Mary Cannon Ref 17 Am J Psychiatry 1997; 154:1703-1710 Objective Documentation of Child Abuse and Dissociation in 12 Murderers With Dissociative Identity Disorder Dorothy Otnow Lewis, M.D. Ref 149 Am J Psychiatry 1997; 154:1715-1719 Characteristics of Borderline Personality Disorder Associated With Suicidal Behavior Beth S. Brodsky Ref 212 Am J Psychiatry 1997; 154:1757-1759 Sexual Functioning in Chronically Depressed Patients Treated With SSRI Antidepressants: A Pilot Study Lisa A. Piazza, M.D Ref 94 Am J Psychiatry; 155:4-11, 1998 . Depression and the course of coronary artery disease Alexander H. Glassman and Peter A. Shapiro Ref 92 Am J Psychiatry; 155:12-21, 1998 Mood stabilizer combinations: a review of safety and efficacy Marlene P. Freeman and Andrew L. Stoll Ref 93 Am J Psychiatry; 155:22-9, 1998 . Use of ECT for the inpatient treatment of recurrent major depression Mark Olfson, Steven Marcus, Harold A. Sackeim, James Thompson, and Harold Alan Pincus Ref 226 Am J Psychiatry; 155:30-5, 1998 Long-term outcome of lithium prophylaxis in bipolar disorder: a 5-year prospective study of 402 patients at a lithium clinic Mario Maj, Raffaele Pirozzi, Lorenza Magliano, and Luca Bartoli Ref 8 Am J Psychiatry ; 155:36-42 1998 Double-Blind, Fixed-Dose, Placebo-Controlled Study of Paroxetine in the Treatment of Panic Disorder James C. Ballenger, M.D. Ref 243 Am J Psychiatry; 155(1):48-53, 1998 Haloperidol plasma levels and dose optimization William Coryell, Del D. Miller, and Paul J. Perry Ref 134 Am J Psychiatry 1998; 155, 54-61 Eficácia e Tolerabilidade da Carbamazepina para Agressão na Demência Pierre N. Tariot, Rosemary Erb, Carol Ann Podgorski, Christopher Cox, Shirish Patel, Laura Jakimovich, and Carrie Irvine Ref 143 Am J Psychiatry 1998; 155:84-89 Neurological Abnormalities in Schizophrenic Patients and Their Siblings Baher Ismail, M.D.. Ref 76 Am J Psychiatry; 1998 155(1):90-7, . A direct-interview family study of generalized social phobia Murray B. Stein, Mariette J. Chartier, Andrea L. Hazen, Maria V. Kozak, Manuel E. Tancer, Sheila Lander, Patricia Furer, Donna Chubaty, and John R. Walker Ref 147 Am J Psychiatry 1998 155:140-2 Frequência das Desordens de Personalidade na Internação Psiquiátrica Carlos M. Grilo, Thomas H. McGlashan, Donald M. Quinlan, Martha L. Walker, David Greenfeld, and William S. Edell Ref 96 Am J Psychiatry; 1998 155:220-5 . Depression among cocaine abusers in treatment: relation to cocaine and alcohol use and treatment outcome Richard A. Brown, Peter M. Monti, Mark G. Myers, Rosemarie A. Martin, Timothy Rivinus, Mary Ella Dubreuil, and Damaris J. Rohsenow Ref 3 Am J Psychiatry 1998; 155: 244-249 O Transtorno Obsessivo Compulsivo Influencia a Anorexia Nervosa ? Andreas Thiel, Markus Züger, Georg E. Jacoby, and Gerhard Schüáler Ref 4 Am J Psychiatry 1998; 155:250-254 Eating Attitudes and Behaviors in 1,435 South African Caucasian and Non-Caucasian College Students Daniel le Grange, Ph.D. Ref 276 Am J Psychiatry 1998; 155:264-271 Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections: Clinical Description of the First 50 Cases Susan E. Swedo, M.D. Ref 15 Am J Psychiatry 1998; 155:278-279 Learning and Memory in Rape Victims With Posttraumatic Stress Disorder Melissa A. Jenkins, Ph.D. Ref 101 Am J Psychiatry; 1998 155:367-72 . Randomized, placebo-controlled trial of paroxetine versus imipramine in depressed HIV-positive outpatients Andrew J. Elliott, Karina K. Uldall, Karen Bergam, Joan Russo, Keith Claypoole, and Peter P. Roy-Byrne Ref 198 Am J Psychiatry 1998, 155: 806-811 Relação estre Distúrbios Dissociativos e Abuso Sexual na Infância Roger T. Mulder, Annette L. Beautrais, Peter R. Joyce, and David M. Fergusson Ref 283 Am J Psychiatry 1998; 155:1521-1528 Estudo Prospectivo sobre Discinesia Tardia Margaret G. Woerner, Jose Ma. J. Alvir, Bruce L. Saltz, Jeffrey A. Lieberman, and John M. Kane Ref 193 Am J Psychiatry 1998; 155: 1756-1762 Fluvoxamina para o Tratamento de Binge James I. Hudson, Susan L. McElroy, Nancy C. Raymond, Scott Crow, Paul E. Keck, Jr., William P. Carter, James E. Mitchell, Stephen M. Strakowski, Harrison G. Pope, Jr., Bernard S. Coleman, and Jeffrey M. Jonas Ref 178 Am J Psychiatry 1999 156:531-537, Queixas de falta de memória e início de Demência de Alzheimer Mirjam I. Geerlings, Cees Jonker, Lex M. Bouter, Herman J. Adèr, and Ben Schmand Ref 192 Am J Psychiatry 1998; 155:596–602 O Distúrbio do Pânico é o mesmo para Homens e Mulheres ? Kimberly A. Yonkers, Caron Zlotnick, Jenifer Allsworth, Meredith Warshaw, Tracie Shea, and Martin B. Keller Ref 184 Am J Psychiatry 1999 156:756-760 Uso da Fluvoxamina para Fobia Social Murray B. Stein, Abby J. Fyer, Jonathan R.T. Davidson, Mark H. Pollack, and Brinda Wiita Ref 216 Am J Psychiatry 1999 156:885-890 Resíduos de Haloperidol no Tecido Cerebral Johannes Kornhuber, Andreas Schultz, Jens Wiltfang, Ingolf Meineke, Christoph H. Gleiter, Robert Zöchling, Karl-Werner Boissl, Friedrich Leblhuber, and Peter Riederer Ref 213 Am J Psychiatry 1999 156:990-999 A Clozapina é Superior aos Neurolépticos Convencionais ? Kristian Wahlbeck, Maxim Cheine, Adib Essali, and Clive Adams Ref 181 Am J Psychiatry 1999 156:1000-1006 Risco de Recaída de Depressão ao longo de 15 anos Timothy I. Mueller, Andrew C. Leon, Martin B. Keller, David A. Solomon, Jean Endicott, William Coryell, Meredith Warshaw, and Jack D. Maser Ref 180 Am J Psychiatry 1999 156:1059-1065, Esquizofrenia e Puberdade Precoce das Mulheres Robin Z. Cohen, Mary V. Seeman, Andrew Gotowiec, and Lili Kopala Ref 191 Am J Psychiatry 1998; 155: 1521-1528 Efeito da Clozapina sobre os Sintomas Positivos e Negativos Margaret G. Woerner, Jose Ma. J. Alvir, Bruce L. Saltz, Jeffrey A. Lieberman, and John M. Kane Ref 286 Am J Psychiatry 1998; 155: 1531-1538 Estudo Prospectivo sobre Discinesia Tardia em Idosos: Taxas e Fatores de Risco Margaret G. Woerner, Jose Ma. J. Alvir, Bruce L. Saltz, Jeffrey A. Lieberman, and John M. Kane Ref 234 Am Surg; 1998 64:242-4. Imipramine overdose complicated by toxic megacolon Ref 317 Anxiety Disorders 2001; 183-201 Assessment of Self-Statements in Agoraphobic situations Wiljo JPJ Ref 295 Ann Intern Med. 2002 Jan 1;136(1):42-53. Review The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava. Ernst. E. Ref 43 Arch Intern Med 1998 158:62-66 Cocaína e Infarto do Miocárdio Ref 124 Arch Int Med 1998; 158:1365-73 Sensação de "Bolo na Garganta" Ref 164 Arch Gen Psychiatry 1979; 36:414–419 Morbidity and rate of undiagnosed physical illnesses in a psychiatric clinic population. Koranyi E Ref 55 Arch Gen Psychiatry 1993 50: 690-8; Alcoholism and Major Depression in Women: A twin Study of the Causes of Comorbidity K. S. Kendler; A. C. Heath; M. C. Neale; R. C. Kessler; L. J. Eaves Ref 287 Arch Gen Psychiatry 1993; 50:723 –733 Identifying risk factors of tardive dyskinesia among long-term outpatients maintained with neuroleptic medications: results of the Yale Tardive Dyskinesia Study. Morgenstern H Ref 244 Arch Gen Psychiatry 1995 52: 756-765; Risk of Tardive Dyskenisia in Older Patients: A Prospective Longitudianl Study of 266 Outpacients D. V. Jeste; M. P. Caligiuri; J. S. Paulsen; R. K. Heaton; J. P. Lacro; M. J. Harris; A. Bailey; R. L. Fell; L. A. McAdams Ref 220 Arch Gen Psychiatry 1995; 52:837–845 Plasma haloperidol levels and clinical effects in schizophrenia and schizoaffective disorder. Volavka J Ref 68 Arch Gen Psychiatry 1996 53: 283-290, The Role of Psychotherapy in the Treatment of Depression: Review of Two Practice Guidelines J. B. Persons; M. E. Thase; P. Crits-Christoph Ref 233 Arch Gen Psychiatry 1997:54; 9-13 Fortt Years of Lithium Treatment M. Schou Ref 218 Arch Gen Psychiatry 1997; 54:49–55 Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment. Viguera AC Ref 183 Arch Gen Psychiatry 1997; 54:633–639 O primeiro Episódio de Depressão Simpson HB Ref 277 Arch Gen Psychiatry. 1997;54:643-648 Utilization of Medical Specialists by Anxiety Disorder Patients BARBARA L. KENNEDY M.D. Ref 36 Arch Gen Psychiatry. 1997;54:897-903 Primeiro Episódio de Depressão Judith L. Rapoport, MD Ref 28 Arch Gen Psychiatry. 1997;54:915-922 Vascular Depression Hypothesis George S. Alexopoulos, MD Ref 219 Arch Gen Psychiatry 1997; 54:953–958 Delayed normalization of central D2 dopamine receptor availability after discontinuation of haloperidol decanoate: preliminary findings. Nyberg S, Farde L, Halldin C Ref 95 Arch Gen Psychiatry; 1998 55(1):49-55,. Twelve-month outcome after a first hospitalization for affective psychosis Stephen M. Strakowski; Paul E. Keck Jr; Susan L. McElroy; Scott A. West; Kenji W. Sax; John M. Hawkins; Geri F. Kmetz; Vidya H. Upadhyaya; Karen C. Tugrul; Michelle L. Bourne Ref 77 Arch Gen Psychiatry; 1998 55(1):56-64,. The risk for early-adulthood anxiety and depressive disorders in adolescents with anxiety and depressive disorders Daniel S. Pine; Patricia Cohen; Diana Gurley; Judith Brook; Yuju Ma Ref 102 Arch Gen Psychiatry; 1998 55(3):250-8,. Depressive signs and symptoms in schizophrenia: a prospective blinded trial of olanzapine and haloperidol Gary D. Tollefson; Todd M. Sanger; Yili Lu; Martha E. Thieme Ref 205 Arch Gen Psychiatry.1998 ;55:259-265 Depressão Como Recaída do Alcoolismo Shelly F. Greenfield; Roger D. Weiss; Larry R. Muenz; Lisa M. Vagge; John F. Kelly; Lisa R. Bello; Jacqueline Michael Ref 265 Arch Gen Psychiatry 1998: 55; 310-316 Prática Médica de Prescrição de Antidepressivos Mark Olfson; Steve C. Marcus; Harold Alan Pincus; Julie M. Zito; James W. Thompson; Deborah A. Zarin Ref 25 Arch Gen Psy. 1998; 55:425-432 Risk Factor for Binge Disorder Christopher G. Fairburn; Helen A. Doll; Sarah L. Welch; Phillipa J. Hay; Beverley A. Davies; Marianne E. O'Connor Ref 174 Arch Gen psychiatry 1999;56:63-9 Acompanhamento prolongado da Bulimia Nervosa Pamela K. Keel; James E. Mitchell; Kathryn B. Miller; Traci L. Davis; Scott J. Crow Ref 165 Arch Gen Psychiatry. 1999;56:821-827 Tratamento Prolongado do Pânico com Agorafobia Matig R. Mavissakalian; James M. Perel Ref 272 Arch Gen psychoatry 1999; 56: 867-874 Orientação Sexual e Risco de Suicídio Richard Herrell; Jack Goldberg; William R. True; Visvanathan Ramakrishnan; Michael Lyons; Seth Eisen; Ming T. Tsuang Ref 166 Arch Gen Psychiatry. 1999;56:932-939 Tratamento da Síndrome Pré-Menstrual com Antidepressivos Ellen W. Freeman; Karl Rickels; Steven J. Sondheimer; Marcia Polansky Rerf 160 Arch Gen Psychiatry. 1999;56:1009-1015 Estabilidade da Personalidade Patológica a Longo Prazo Mark F. Lenzenweger Ref 161 Arch Gen Psychiatry. 1999;56:1073-1086 Tratamento do Détict de Atenção por Hipertatividade The MTA Cooperative Group Ref 321 Arch Gen Psychiatry 2001; 58(3): 257-265 The Genetic Epidemiology of Irrational Fears and Phobias in Men Kendler, Kenneth S Ref 337 Arch Gen Psychiatry, 2001 58(6): 590-596 The Prevalence of Personality Disorders in a Community Sample Torgersen Svenn Ref 324 Arch Gen Psychiatry, 2001 58(10). .909-915 Neuropsychological Performance in Long-term Cannabis Users Pope Harrison Ref 129 Arch Fam Med 1996 5:27-34; Prevalence of Comorbid Anxiety Disorders in Prynary Care Outpatients Ref 106 Arch Int Med 1998 Vol 158 pag 397 Depressão em Pacientes Hospitalizados Ref 278 Arch Int Med 1998 Vol 158, pag 705 Eficácia do Tratamento de Depressão nos Idosos em Ambulatório Ref 113 Arch Int Med 1998 Vol 158 pag 929 Taquicardia Paroxística num Paciente sem Pânico Ref 114 Arch Int Med 1998 Vol 158 pag 1099 Insônia em Pacientes com Doenças Crônicas Ref 167 Arch Intern Med. 1999;159:2129-2137 Síndrome da Fadiga Crônica Ref 84 Aten Primaria; 1998 21(5):265-9, Prevalence of mental diseases in women of an urban area. Ref 312 Aust Fam Physician. 2001 May;30(5):447-50. Naltrexone and acamprosate. Using new drugs for alcohol dependence. Tedeschi M Ref 86 Aust N Z J Psychiatry 1998; 32(1):67-72,. The prevalence of comorbid anxiety in schizophrenia, schizoaffective disorder and bipolar disorder Ref 69 Behav Res Ther 34: 447-452, 1996 Treatment of Generalized Social Phobia: Results at Long-Term Follw-Up Ref 242 Biol Psychiatry; 43(6):464-5, 1998 Sertraline in the treatment of depression associated with gonadotropin-releasing hormone agonist therapy Ref 87 Biol Psychiatry; 43(11):840-2, 1998 Jun 1 Sleep Deprivation in social phobia and generalized anxiety disorder Ref 224 Br Dent J; 183(11-12):399-407, 1997 Dec 13-27. Memory and midazolam conscious sedation Ref 290 Br. J Psychiatry 1992; 160 (Suppl15) 50-55 The Effects of Tianeptine and the others antidepressants on Depression Curzon G Ref 64 Br. J Psychiatry 1995 166: 489-495 Child and Adolescent (Juvenile Onset) Schizophrenia: A Case Control Study of Premorbid Developmental Impairments Ref 131 Br. J. Psychiatry 1995 166; 793-797: Chronic Fatigue Syndrome in the Community: Prevalence and Associations Ref 182 Br J Psychiatry 1998; 172:29–34 Recurrence in affective disorder, II: effect of age and gender. Kessing LV Ref 82 Br J Psychiatry; 1998 172:70-7,. Placebo-controlled trial of moclobemide in social phobia Ref 298 Br Med Bull. 2001;57:161-78 Meta-analytical studies on new antidepressants. Anderson IM Ref 38 Brit. Med. J 1997; vol II n11 pag 13 Transtorno Obsessivo Compulsivo na Infância Ref 123 Brit. Med J 1998; 317: 303-12 Terapia Comportamental para Esquizofrenia Nicholas Tarrier, Lawrence Yusupoff, Caroline Kinney, Eilis McCarthy, Ann Gledhill, Gillian Haddock, and Julie Morris Ref 236 Brit. Med. J. 1998, No 7131 pag 595 Hipotensão Postural e Paroxetina C Andrews and G Pinner Ref 46 Brit. Med. J 1998, No 1725 pag 117 Dependência Física ao Zopiclone Ian R Jones and Gary Sullivan Ref 47 Brit. Med. J. 1998; No 7127 pag 244-6 Esteróides e Depressão Alexander Mitchell and Veronica O'Keane Ref 261 Brit. Med. J. Vol 316 No 7131 Feb 1998 pag 564 Sintomas Neurológicos não Explicados Michael D O' Brien Ref 284 Brit. Med J V 316 No 7135 1998 Dor fantasma, Ansiedade e Depressão Ref 238 Brit. Med. J. V 316 No 7138 1998 Reação de Interrupção dos Antidepressivos Ref 260 Brit. Med J Vol 316 N 7139 1998 Hipoatividade Cerebral em Disléxicos Ref 259 Brit. Med. J. Vol 316 N 7140 1998 Suicídio Pós AVC Ref 108 Brit. Med J Vol 316 N 7139 1998 Dor Abdominal não Explicada em Crianças Ref 121 Brit Med J 1998; No 7146 pag: 1714-9 Depression as Risk Factor for Ischemic Hert Disease in Men: Population Base Case-control Study Julia Hippisley-Cox, Katherine Fielding, and Mike Pringle Ref 122 Brit Med J 1998; pag 1884-6 Depressão Pós-Parto - Revisão Peter J Cooper and Lynne Murray Ref 106 Brit. Med Journal V 316 No 7135 mar 1998 Saúde Mental em Crianças Abandonadas Ref 339 Brit Med J 2001; pag 1408 First Episode Psychosis Helen Lester Ref 74 Can J Psychiatry; 42(8):826-34, 1997 Oct. Assessment and treatment of social phobia Martin M Antony, Ref 210 Can J Psychiatry 1997; 42: 1043-50 Efficacy and Tolerability of Mocloemide in Comparison with Placebo, Tricyclic Antidepressants, and Selective Serotonin Reuptake Inhibitos in Elderly Depressed Patients: A Clinical Overview. Roman Amrein, MD, Max Stabl, MD, Stephan Henauer, MD, Eva Affolter, Iris Jonkanski Ref 31 Can J Psy 1997; 42: 1061-5 Breat-Feeding and Postpartum Depression: Is there a Relation ? 152 Shaila Misri, MD, FRCPC, Dana A Sinclair, PhD, Annie J Kuan, BA Ref 207 Can J Psychiatry 1998; 43: 57-63 The Nature and Characteristics os Psychiatric Comorbidity in Incarcerated Adolescent Ref 10 Can J Psy 1998; 43:73-77 Efficacy of Divalproex Sodium in Patients with Panic Disorder and Mood instability Who Have Not Responded to Conventional Therapy Ref 150 Can J Psy. 1998; 43: 148-153 Does Childhood Trauma Cause Personality Disorders In Adults ? Ref 144 Can J Psy 1998; 43: 180-182 DSM-III-R Schizofreniform Disorder With Good Prognostic Features: A Six-Year Follow-Up Ref 329 Can Med Ass J 2001; 165: 917-929 The Pharmacology and Toxicology of Ecstasy Harold Kalant Ref 230 Clin Geriatr Med; 1998 14(1):177-89,. Estrogen as a psychotherapeutic agent Ref 307 Clin Pharmacokinet. 2001;40(7):509-22. Clinical pharmacokinetics of quetiapine: an atypical antipsychotic. DeVance CL Ref 211 Clin Pharmacol Ther; 1998 63(4):403-13, Pharmacokinetic and pharmacodynamic interactions between fluoxetine and moclobemide in the investigation of development of the ®serotonin syndrome Ref 201 Compr Psychiatry 1993; 34:258–263 Correlates of dissociative symptomatology in patients with physical and sexual abuse histories. Kirby JS, Chu JA, Dill DL: Ref 56 Compr Psychiatry 1995 36:319-328; Specificity of Substances Use in Anxiety-disorders Subjects Ref 58 Compr Psychaitry 1995 36: 271-277; 5-Year Prospective Naturalistic Follow Up Study of Panic Disorder Ref 57 Compr Psychiatry 1995 36: 296-302; Better Than Expected : Improvment in Borderline Personality Disorder in a 3-Year Prospective Outcome Study Ref 75 Compr Psychiatry; 1997 38(6):315-20, Comorbidity of panic disorder with agoraphobia and specific phobia: relationship with the subtypes of specific phobia Ref 81 Depress Anxiety; 1997 6(2):78-85, Hypochondriacal concerns and somatization in panic disorder Ref 291 Drug and Alcohol Dependence 2000; 58, 237-245 Sexual and Drug Behaviors Among Female Crack Users Ref 225 Drugs; 1998 55(1):85-120,. Paroxetine. An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders Ref 310 Drugs. 2000 Apr;59(4):865-89. Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia. Soyka M Ref 301 Drugs. 2000 Oct;60(4):925-54. Fluvoxamine. An updated review of its use in the management of adults with anxiety disorders. Figgitt DP Ref 311 Drugs. 2000 Aug;60(2):413-45. Zaleplon: a review of its use in the treatment of insomnia. Dooley M Ref 300 Drugs. 2001;15(8):643-69 Venlafaxine extended-release: a review of its use in the management of major depression. Wellington K Ref 279 Drugs Aging; 11(3):170-7, 1997 Sep. Diagnosis and treatment of psychotic symptoms in elderly patients Ref 266 Drugs Aging; 12(1):55-74, 1998 Jan. Depression in Parkinson's disease. Pharmacological characteristics and treatment Ref 303 Drug Rev. 2001 Spring;7(1):1-24. The selective serotonin reuptake inhibitor sertraline: its profile and use in psychiatric disorders. MacQueen G Ref 297 Drug Rev. 2001 Spring;7(1):25-47. Paroxetine: a review. Bourin M. Ref 302 Drug Rev. 2001 Fall;7(3):249-64 A review of the pharmacological and clinical profile of mirtazapine. Anttila SA Ref 228 Drug Saf; 1998 18(1):57-82,. Risks and benefits of selective serotonin reuptake inhibitors in the treatment of depression Ref 126 Epilepsia; 39(4):432-7, 1998 Factors distinguishing families of patients with psychogenic seizures from families of patients with epilepsy Ref 250 Epilepsia; 39(5):478-86, 1998 Psychiatric outcome of temporal lobectomy for epilepsy: incidence and treatment of psychiatric complications Ref 127 Epilepsia; 39(6):595-9, 1998 Symptoms of depression and anxiety in pediatric epilepsy patients Ref 208 Eur Arch Psychiatric Clin Neurosc. 1998; 248: 87-95 Comorbidity Patterns in Adolescents and Young Adults With suicide Attempts Ref 299 Eur Neuropsychopharmacol. 2001 Aug;11(4):275-83. Review of pharmacokinetic and pharmacodynamic interaction studies with citalopram. Brozen K Ref 319 Eur Psychiatry 2000: 15; 5-16 A European Perspective on Social Anxiety Disorder Y Lecrubier Ref 327 Eur Psychiatry 2000: 15; 287-294 Agony and Ecstasy: A reveiw fo MDMA effects C. Burgess Ref 341 Eur. Psychiatry 2001: 16, 90-8 Relapse Prevention in Schizophrenia J Bergiannaki Ref 314 Eur. Psychiatry 2001: 16, 232-8 The Prognostic Value of Initial EDI scores in Anorexia Nervosa C. Bizeul Ref 333 Eur. Psychiatry 2001; 16: 327-335 Relapse and Recurrence Prevention in Major Depression JG storesum Ref 309 Expert Opin Pharmacother. 2000 Jan;1(2):305-23. Olanzapine: an atypical antipsychotic for schizophrenia. Ref 306 Expert Opin Pharmacother. 2000 Dec;1(7):1441-53. Pharmacology and clinical experience with risperidone. Love RC Ref 267 Gen Hosp Psychaitry 18: 22-27, 1996 Do Primary Care Patients Accept Psychological Treatment ? Ref 325 Health Edu Res 2001; 4: 457-469 Understanding Reasons for Drug Use Among Young People Annabel Boys Ref 340 Hospital Physician 2001; 50: 21-28 New Hope in Pharmacotherapy for Schizophrenia Leonardo Cortese Ref 80 Int Clin Psychopharmacol; 12(5):239-54, 1997. Social phobia: long-term treatment outcome and prediction of response--a moclobemide study Ref 313 Int J Clin Pract. 2001 Jan-Feb;55(1):53-7. The pharmacology underlying pharmacotherapy for tobacco dependence: a focus on bupropion. Balfour J Ref 175 Int J Eat Disord 1999 25:1 19-27 Effectiveness of fluoxetine therapy in bulimia nervosa regardless of comorbid depression. Goldstein DJ Ref 88 Eur J Surg Suppl; (580):27-32, 1998. Treatment of social phobia by endoscopic thoracic sympathicotomy Ref 235 J Affec Dis 49: 19-26; 1998 Pesquisa de uso de Antidepressivos através do Telefone Ref 293 J Affect Disord 1998 Dec; 51(3):345-51 The scientific, quasi-scientific and popular literature on the use of St. John's Wort in the treatment of depression Deltito J, Beyer D Ref 232 J Affect Disord; 47(1-3):177-82, 1998 Jan. Rates of flu-like infection in patients with affective illness Ref 39 JAMA Vol 279 N4 1998 pag 287 Paroxetina x Nortriptilina p/ depressão em pacientes com isquemia cardíaca Steven P. Roose; Fouzia Laghrissi-Thode; John S. Kennedy; J. Craig Nelson; J. Thomas Bigger Jr; Bruce G. Pollock; Andrew Gaffney; Meena Narayan; Mitchell S. Finkel; James McCafferty; Ivan Gergel Ref 52 JAMA Vol 279 No 5 pag 376 04/02/98 Lesão Cerebral Induzida pela Cocaína Marc J. Kaufman; Jonathan M. Levin; Marjorie H. Ross; Nicholas Lange; Stephanie L. Rose; Thellea J. Kukes; Jack H. Mendelson; Scott E. Lukas; Bruce M. Cohen; Perry F. Renshaw Ref 240 JAMA Vol 279 N 7 fev/98 pag 526 Tendências de Prescrição de Psicotrópicos Harold Alan Pincus; Terri L. Tanielian; Steven C. Marcus; Mark Olfson; Deborah A. Zarin; James Thompson; Julie Magno Zito Ref 45 JAMA Vol 279 N7 fev/98 pag 535 Álcool e Câncer de Mama Stephanie A. Smith-Warner; Donna Spiegelman; Shiaw-Shyuan Yaun; Piet A. van den Brandt; Aaron R. Folsom; R. Alexandra Goldbohm; Saxon Graham; Lars Holmberg; Geoffrey R. Howe; James R. Marshall; Anthony B. Miller; John D. Potter; Frank E. Speizer; Walter C. Willett; Alicja Wolk; David J. Hunter Ref 229 JAMA Vol 279 N 8 1998 pag 609 Teratologia e Inibidores da Recaptação da Serotonina Nathalie A. Kulin; Anne Pastuszak; Suzanne R. Sage; Betsy Schick-Boschetto; Glenda Spivey; Marcia Feldkamp; Kelly Ormond; Doreen Matsui; Amy K. Stein-Schechman; Lola Cook; Joanne Brochu; Michael Rieder; Gideon Koren Ref 48 JAMA Vol 279 No 9 1998 pag 688 Prevenção de Demência com Estrogênio em Mulheres após a Menopausa Kristine Yaffe; George Sawaya; Ivan Lieberburg; Deborah Grady Ref 120 JAMA 1998; 279: pag: 1975-1980 Morte Causada por Cocaína em Dias Muito Quentes Ref 112 JAMA 1998 Vol 279 N 14 pag 1100 Diagnóstico e Tratamento do Défict de Atenção com Hiperatividade Larry S. Goldman; Myron Genel; Rebecca J. Bezman; Priscilla J. Slanetz; for the Council on Scientific Affairs, American Medical Association Ref 89 JAMA; 280(8):708-13, 1998 Aug 26 Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomized controlled trial Ref 115 JAMA Vol 280 pag 1133 1998 Relação entre AVC e Depressão Ref 116 JAMA Vol 158 pag 1197 1998 Prevenção da Hipertensão Prevenindo-se o Alcoolisno Ref 197 JAMA 1991; 265:1545 –1549 Follow-up status of patients with angiographically normal coronary arteries and panic disorder. Beitman BD Ref 156 JAMA. 2000;284:963-971 Odansetrona Ref 177 J Affect Disord 1998; 48:157–161 Testosterone replacement therapy for hypogonadal men with SSRI-refractory depression. Seidman SN Ref 293 J Affect Disord 1998 Dec; 51(3):345-51 The scientific, quasi-scientific and popular literature on the use of St. John's Wort in the treatment of depression Deltito J, Beyer D JAMA. 2002 Apr 10;287(14):1807-14 Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial. Ref 67 J Am Acad Child Adoled Psychiatry 34: 1560-1576, 1995 Neuroimaging in Child and Adolecent Neuropsychiatric Disorders Ref 60 J Am Acad Child Adolesc Psychiatry 35: 134-143; 1996 Treatment of Autistic Disorder Ref 66 J Am Acad Child Adolec Psychiatry 1996 35: 451-460 Origins of Comorbidity Between Conduct and Affective Disorders Ref 2 J. Am. Acad. Child Adolesc. Psychiatry, 1997, 36(1):9-20 Pediatric Sleep Disorders: A Review of the Past 10 Years Ref 33 J. Am. Acad. Child Adolesc. Psychiatry, 1997, 36(7):918-924 At Risk for Anxiety: I. Psychopathology in the Offspring of Anxious Parents DEBORAH C. BEIDEL Ref 34 J. Am. Acad. Child Adolesc. Psychiatry, 1997, 36(9):1195-1203 Gender and Comorbid Psychopathology in Adolescents With Alcohol Dependence DUNCAN B. CLARK, PH.D. Ref 35 J. Am. Acad. Child Adolesc. Psychiatry, 1997, 36(10):1457-1464 Low Resting Heart Rate at Age 3 Years Predisposes to Aggression at Age 11 Years: Evidence From the Mauritius Child Health Project ADRIAN RAINE Ref 206 J. Am. Acad. Child Adolesc. Psychiatry, 1998, 37(2):221-227 Spectrum of Neuroleptic-Induced Movement Disorders and Extrapyramidal Side Effects in Childhood-Onset Schizophrenia SANJIV KUMRA, M.D. Ref 128 J Am Acad Child Adolesc Psychiatry; 1998 37(4):386-94, Sertraline treatment of children and adolescents with obsessive-compulsive disorder or depression: pharmacokinetics, tolerability, and efficacy Ref 202 J Am Acad. Child Adolesc Psychiatry 1998, 37(6): 594-601 Distúrbios de Conduta na Adolescente e Problemas Médicos no Adulta Ref 195 J Am Acad Child Adolesc Psychiatry 1998, 37(6): 602-611 Problemas Gerais e Depressivos nos Filhos de Pacientes Deprimidos Ref 90 J Anxiety Disord; 12(3):209-23, 1998 May-Jun. An investigation of gender differences in social phobia Ref 91 J Anxiety Disord; 12(3):233-51, 1998 May-Jun. Stressful life events and personality styles: relation to impairment and treatment outcome in patients with social phobia Ref 318 J Anxiety Disord; 14(1): 31-40, 2001 Generalized Anxiety Disorder: So Where Do We Stand? Michel Dugas Ref 40 J Biological Rhythms 1997, vol 12 N 6 pag 532 O que a Melatonina Faz ? Ref 223 J Clin Psychiatry 56:177-178, 1995 Medication Use During Pdychoanalysis: A Survey Stephen J. Donovan and Steven P. Roose Ref 170 J Clin Psychiatry 1995 Dec 56:12 556-9 Risperidona versus clozapina no tratamento de sintomas psicóticos de pacientes com parkinson. Stuart S. Rich, Joseph H. Friedman, and Brian R. Ott Rich SS Ref 32 J Clin Psychiatry; 58(11):470-8, 1997 Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder Kirk D. Denicoff, Earlian E. Smith-Jackson, Elizabeth R. Disney, S. Omar Ali, Gabriele S. Leverich, and Robert M. Post Ref 71 J Clin Psychiatry; 58(11):479-83, 1997 Nov. Olanzapine in treatment-refractory schizophrenia: results of an open-label study. Joaquín Martín, Juan-Carlos Gómez, Enrique García-Bernardo, Manuel Cuesta, Enrique Alvarez, Manuel Gurpegui, and the Spanish Group for the Study of Olanzapine in Treatment-Refractory Schizophrenia Ref 61 J Clin Psychiatry; 58(11):484-91, 1997 A double-blind, placebo-controlled study comparing the effects of sertraline versus amitriptyline in the treatment of major depression: R. Bruce Lydiard, Stephen M. Stahl, Marc Hertzman, and Wilma M. Harrison Ref 269 J Clin Psychiatry; 58(11):510-5; 1997 Determinants of suicidal ideation: the role of substance use disorders Kenneth P. Pages, Joan E. Russo, Peter P. Roy-Byrne, Richard K. Ries, and Deborah S. Cowley Ref 62 J Clin Psychiatry; 58(12):522-7, 1997 Lamotrigine in rapid-cycling bipolar disorder S. Hossein Fatemi, Daniel J. Rapport, Joseph R. Calabrese, and Paul Thuras Ref 63 J Clin Psychiatry; 58(12):528-31, 1997 Venlafaxine in dysthymic disorder Ref 72 J Clin Psychiatry; 58(12):538-46, 1997 The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials Ref 73 J Clin Psychiatry; 58(12):555-61; 1997 Dec Determinants of pharmacologic treatment failure in panic disorder Ref 11 J Clin Psychiatry; 59(2):49-55, 1998 Feb. Should anxiety and insomnia influence antidepressant selection: a randomized comparison of fluoxetine and imipramine Ref 79 J Clin Psychiatry; 59(2):60-8, 1998 Feb. Occurrence and clinical correlates of psychiatric comorbidity in patients with psychotic disorders Ref 104 J Clin Psychiatry; 59(3):103-7, 1998 Mar. Low-dose clozapine in acute and continuation treatment of severe borderline personality disorder Ref 305 J Clin Psychiatry. 2000;61 Suppl 8:14-7 Review and management of clozapine side effects. Miller DD Ref 296 J Clin Psychiatry. 2001;62 Suppl 22:24-9 Fluoxetine: a suitable long-term treatment. Calil HM Ref 304 J Clin Psychiatry. 2002;63(1):10-7 Pharmacology of antidepressants: focus on nefazodone. DeVane CL Ref 20 J Clin Psychopharmacol 1997; 17: 485-8 Medicação para Substituição da Cocaína em dependentes: Metilfenidato Ref 231 J Clin Psychopharmacol; 18(1):19-25, 1998 Feb. The use of venlafaxine in the treatment of major depression and major depression associated with anxiety: a dose-response study. Venlafaxine Investigator Study Group Ref 98 J Clin Psychopharmacol; 18(1):38-49, 1998 Feb Lithium plus valproate as maintenance polypharmacy for patients with bipolar I disorder: a review Ref 85 J Clin Psychopharmacol; 18(2):132-5, 1998 Apr. Imipramine in the treatment of social phobia Ref 130 J Consult Clin Psychol Diagnostic Comorbidity in Panic Disorder: Effect on Treatment Outcome and Course of Comorbid Following Treatment Ref 54 J Gen Intern Med 10: 663-70; 1995 Outcome of Inadequate Antidepressants Treatment Ref 273 J Health Soc Behav 1995 Mar;36(1):38-56 Estresse e Saúde Mental de Homoxessuais Masculinos Meyer IH Ref 65 J Nerv Ment Dis 184: 99-102, 1996 Antidepressants for Children: Is Scientific Support Necessary ? Ref 29 J Nerv. Ment. Dis. 1997; 185: 748-54 Dificuldade de Atenção entre as fases de Depressão Ref 14 J Nerv Ment Dis 1997; 185:755-60 Sintomas Dissocativos na Desordem do Pânico Ref 151 J Nerv Ment Dis; 186(2):87-95, 1998 Feb. Personality disorders in substance abusers: relation to substance use Ref 83 J Nerv Ment Dis; 186(4):201-6, 1998 Apr Tourette's disorder with and without obsessive-compulsive disorder in adults: are they different? Ref 189 J Neurol 1990; 237:35 –38 Natural history and outcome of psychogenic seizures: a clinical study in 50 patients. Lempert T Ref 190 J Neurol Neurosurg Psychiatry 1997; 63:83–88 Binzer M Clinical characteristics of patients with motor disability due to conversion disorder Ref 171 J Neurol Neurosurg Psychiatry 1998 Nov 65:5 774-7 Olanzapine in the treatment of hallucinosis in idiopathic Parkinson's disease: a cautionary note. Graham JM Ref 203 J Neuropsychiat Clin Neurosc 1998; 10:20–25 Estimulação Magnética Transcraniana Rápida para Depressão Resistente Ref 275 J Neuropsychiatry Clin Neurosci 11:176-189, May 1999 Uso de Psicotrópicos em Pacientes com Distúrbios Neurológicos Ref 274 J Neuropsychiatry Clin Neurosci 11:190-208, May 1999 Uso da Eletroencefalografia em Psiquiatria Ref 26 J Psychiatric Res. 1998; 32: 1-9 The Value of REM sleep parameters in differentiating Alzheimer Demencia from Old Age Depression and Nomal Aging Ref 332 J Psychiatry Res. 2000; 48: 493-500 Severe Depression is Associated with Markedly Reduced Heart Rate? Phillis K Stein Ref 331 J Psychiatry Res. 2001; 51: 659-663 Does the edinburg Postnatal Depression Rating scale Measure Anxiety? Evelien Brouwers Ref 323 J Psychossomatic Res. 2000; 48: 347-356 Is Panic Disorder Associated with Coronary Desease? Richard Fleet Ref 70 J Psychother Prac Res 5: 185-201, 1996 Psychotherapy and Schizophrenia Ref 241 J Sex Marital Ther; 24(1):3-12, 1998 Sexual dysfunction induced by serotonin reuptake antidepressants Ref 215 N Engl J Med 1997; 337:809–815 A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. Rosenheck R Ref 103 J Psychos Res 1998: 44; 385-405 Transtorno do Comer Compulsivo Ref 105 J Psychossom Res 44: 491-502; 1998 Sexualidade em Pacientes com Bulimia Ref 249 J Urol; 159(6):1935-8, 1998 Treatment of premature ejaculation with sertraline hydrochloride: a single-blind placebo controlled crossover study Ref 271 Lancet Vol 351 N 9096 10/01/98 pag 82 Psoríase e Stress Ref 262 Lancet Vol 351 N 9096 pag 93 10/01/98 Fatores Preditores de Suicídio Ref 263 Brith Med. J, 1998: No 7125 pag 106-9 Avaliação Randomizada e dois Modelos de Alta Psiquiátrica Ref 53 Lancet 1998 Vol 351 N 9096 pag 109 Estrogênio para depressão pós-parto Ref 50 Lancet 1998 Vol 351 No 9100 pag 429 Hiperatividade com Déficit de Atenção Ref 49 Lancet 1998 Vol 351 No 9101 pag 465 Fisiopatologia da Síndrome Pré-Menstrual Ref 237 Lancet 1998 Vl 351 No 9205 pag 802 Galactorreia com Moclobemida Ref 117 Lancet 1998; 351: 1631 Fatores Predisponentes a Mortalidade em Alzheimer Ref 111 Lancet Vol 351 N 9112 pag 1303 1998 ISRS em idosos Ref 254 The Lancet 1998; 351: 1601 Epidemiologia e Prática Psiquiátrica Ref 253 Lancet 1998; 351: 1673 Definições sobre a memória e a falta de memória Ref 18 Lancet 1998; 351: 1840 Fumo e Demência de Alzheimer Ref 268 Nature 378: 68-70, 1995 Sex Difference in the Human Brain and Its Relation to Transsexuality Ref 221 Nephrol Dial transplant 11: 457-460; 1996 Renal Function on and off Lithium in Patients Treated with Lithium for 15 Years or More Ref 145 Neurobiology 1998; 37: 186-193 Immunological Dysfunction in Schizophrenic: A Sistematic Approach Ref 336 Neurobiology of Aging 2000; 21: 49-55 Midlife Blood Pressure and Dementia Lenore Launer Ref 248 Neurology 1997; 49: 1587-90 Clozapina na Doença de Parkinson: Efeitos agudos e Crônicos. Ref 255 Neurology Vol 50 Suppl 6 pag 33 1998 Controle dos Sintomas neuropsiquiátricos nos pacientes com Parkinson Ref 110 Neurology vol 50 n 5 pag 1222 1998 Tratamento do Deficit Cognitivo do Alzheimer com Metrifonato Ref 257 Neurology vol 50 n 5 pag 1238 1998 Performance Cognitiva e Etnia Ref 256 Neurology vol 50 n 5 pag 1246 1998 Inteligência e tamanho cerebral Ref 119 Neurology 1998; 50: 1541-45 Fatores Familiares na Demência Frontotemporal Ref 51 New England J Med Vol 338 N 4 jan/98 pag 209-16 Síndrome Pré-Menstrual Ref 264 New England Vol 338 No 7 pag 464 12/02/98 Tratamento de Parafilias Ref 44 New England J Med Vol 338 N 8 fev/98 pag 506 Genética e Diagnóstico de Alzheimer Ref 42 New England J Med Vol 338 N 9 fev/98 pag 592 Tratamento do Alcoolismo e Naltrexona Ref 258 N. England J Med vol 338 n 14 pag 970 1998 Status Epileticus Ref 109 N Engl J Med vol 338 n 17 pag1231 1998 Relações Culturais na Anorexia Nervosa Ref 251 N Eng J Med 1998; 338: 1715-22 Prognóstico das Convulsões Infantis Ref 251 N Eng J Med 1998; 338: 1723-28 Prognóstico Intelectual e Comportamental das Crianças com Convulsões febris Ref 239 N Eng. J Med 1998; 338: 1869-75 Diazepam em Gel via Retal para Convulsões Repetitivas Ref 173 N Engl J Med 1999; 340:333-9 Indução de Aborto pela Cocaína e Tabaco Ref 169 N Engl J Med 1999;340:757-63 Clozapina para Tratar Sintomas Psicóticos em Pacientes com Parkinson Ref 168 N Engl J Med 1999:780-8 Tratamento do Déficit de Atenção por Hiperatividade Ref 172 New Engl J Med 1999; May 13: p 1482-90 Tratamento Farmacológico Para Dependência Alcoólica Ref 97 Nord Med; 113(1):13-5, 15, 1998 Jan Nocturnal enuresis in children Ref 179 Program. Neuroepidemiology 1994; 13:145–154 Self-reported memory complaints and memory performance in elderly French community residents: results of the PAQUID Research Gagnon M, Dartigues JF Ref 247 Psychol Med 25: 1073-1086; 1995 Symptons of Psychological Precist 7-Year Mortality Ref 214 Psychopharmacol Bull 1996; 32:683–697 Clozapine's effectiveness for patients in state hospitals: results from a randomized trial. Essock SM Ref 158 Psychiatr Clin North Am, 20(4):723-39 1997 Dec Generalized Disorder Ref 320 Psychiatry Res. 1998; 81: 179-193 Epidemiological and Phenomenological Aspects of Post-Traumatic Stress Disorder Michael Maes Ref 338 Psychiatry Res. 2000; 97: 165-172 Psychometric Assessment of Subjective Sleep Quality Yorico Doi Ref 315 Psychiatry Research 2001; 103 15-26 Self-Destructiveness and Serotonin Function in Bulimia Nervosa Howard Steiger Ref 336 Psychiatry Research 2001; 103:219-228 Clinical Features of Dysthymia and Age Silvio Bellino Ref 330 Psychiatry Research 2001; 103: 229-235 Age of Onset of Bipolar II Derpessive Mixed State Franco Benazzi Ref 334 Psychiatry Research 2001; 104: 175-181 Symptoms of Atypical Depression Michael Posternak Ref 288 Psychol Med 1993; 23:453 –465 New findings on tardive dyskinesia in a community sample. O ’Hara P Ref 328 Psychopharmacology 2001; 154: 161-168 Gender Differences in the subjective effects of MDMA Matthias Liechti Ref 5 Psychosomatics 1998; 39:61-67 The Evaluation of Eating and Weight Symptoms in the General Hospital Consultation Setting Caroline P. Carney, M. Ref 162 Psychosomatics 1998; 39:253-262 Alterações somáticas nos Pacientes com Transtornos Psicóticos Ref 161 Psychosomatics 1998; 39:263–272 Sintomas somáticos no atendimento primário Ref 194 Psychosomatics 1998; 39:512–518 Transtorno do Pânico nos Serviços de Emergência Médica Ref 187 Psychosomatics 1998; 39:519–527 Acompanhamento de 5 anos de Distúrbio Conversivo Motor Ref 185 Psychosomatics 40:185-192, June 1999 Eventos Vitais Precipitando Depressão Ref 188 Psychother Psychosom 1990; 53:161 –165 Inpatient treatment of conversion disorder: a clinical investigation of outcome. Scifferdecker K Ref 99 Psychother Psychosom; 67(1):3-9, 1998 .What is the role of psychotherapy in the treatment of bipolar disorder Ref 100 Psychother Psychosom; 67(1):50-6, 1998. Treatment of patients with chronic somatic symptoms by means of art psychotherapy: a process description Ref 316 Rev Bras Psiquiatr 2001; 23(1):38-40 Transtorno da Compulsão Alimentar Periódica e TOC. José Carlos Appolinário Ref 322 Rev Bras Psiquiatr 2001; 23(Sup 2):6-9 O Quadro Clínico do TOC Albina Torres Ref 209 Schizophr Bull 21: 419-429; 1995 Cost of Relapse in Schizophrenia Ref 132 Schizophr Bull 22:27-39; 1996 Convulsive Therapy in Schizophrenia ? Ref 141 The Psychiatric Clinics of North America March 1998 Emergin Roles for Novel Antipsychotic Medication in the Treatment of Schizophrenia Ref 152 Dissociação http://users.knoware.nl/users/tamar/article.html Ref 153 Ejaculação Precoce http://www.masculin.com.br/precoce.html http://www.epm.br/cirurgia/uronline/ed1296/novidades.htm#nov2 http://www.sexualidades.com/docs/disfuncoes_recomendacoes.php3#precoc Ref 154 Tensão Pré-Menstrual http://www.pslgroup.com/dg/142032.htm http://www.methodisthealth.com/WomensHealth/gynepmdd.htm http://www.womens-health.org/PMDD.html Ref 155 Insônia http://www.sciam.com/explorations/040196explorations.html http://sleepdisorders.about.com/health/sleepdisorders/msubmelatonin.htm Ref 157 Estresse Pós-Traumático http://www.nlm.nih.gov/medlineplus/posttraumaticstressdisorder.html